Inhibrx Biosciences, Inc. INBX Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s preferred stock, shares authorized?
- Inhibrx Biosciences, Inc. (INBX) reported preferred stock, shares authorized of $15M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s preferred stock, shares authorized changed year-over-year?
- Inhibrx Biosciences, Inc.'s preferred stock, shares authorized decreased by 0.0% year-over-year, from $15M to $15M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s preferred stock, shares authorized?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $15M to $15M.